Suppr超能文献

局部应用0.5%托吡卡胺和1%阿托品对健康宠物兔瞳孔直径、眼压和泪液分泌的影响。

Effects of topical 0.5% tropicamide and 1% atropine on pupil diameter, intraocular pressure, and tear production, in healthy pet rabbits.

作者信息

Cabrero María, Guyonnet Alexandre, Mercado Laura, Andrejak-Benit Juliette, Meric Tristan, Bourguet Aurélie

机构信息

Ophthalmology Unit, Atlantia Veterinary Hospital Center, Nantes, France.

FauneVet, Atlantia Veterinary Hospital Center, Nantes, France.

出版信息

Vet Ophthalmol. 2024 Sep 27. doi: 10.1111/vop.13280.

Abstract

OBJECTIVE

To evaluate the effects of topical application of 0.5% tropicamide and 1% atropine on pupil diameter (PD), intraocular pressure (IOP), and tear production (TP) in healthy pet rabbits.

ANIMALS STUDIED

Ten healthy client-owned rabbits.

PROCEDURES

A prospective, randomized, blinded, crossover study was conducted. Each animal received one drop of 0.5% tropicamide or 1% atropine in a randomly selected eye. PD, IOP, and TP were evaluated before drug instillation and at 0.25 h, 0.5 h, 0.75 h, 1 h, 2 h, 4 h, 6 h, 8 h, 10 h, 12 h, 24 h, 36 h, 48 h, 60 h, and 72 h post-instillation. Data were analyzed using a paired two-sample repeated measures T-test with Bonferroni correction.

RESULTS

In both tropicamide and atropine treated eyes, the mean PD significantly increased from 15 min until 12 h after treatment with a maximum PD at 45 min (+2.7 mm and + 2.4 mm respectively). Following tropicamide and atropine instillation, IOP increased significantly in treated eyes at 45 min (+2.9 mmHg) and 15 min (+5.2 mmHg) respectively, compared to untreated eyes. No significant effects were found on TP, in both tropicamide and atropine treated eyes at any time. No effects were observed in the untreated eyes on any of the parameters evaluated for both drugs.

CONCLUSIONS

Topical treatment with 0.5% tropicamide and 1% atropine induced mydriasis in healthy pet rabbits and could be considered as effective options when mydriatic/cycloplegic drugs are required.

摘要

目的

评估局部应用0.5%托吡卡胺和1%阿托品对健康宠物兔瞳孔直径(PD)、眼压(IOP)和泪液分泌(TP)的影响。

研究动物

十只健康的客户拥有的兔子。

方法

进行一项前瞻性、随机、双盲、交叉研究。每只动物在随机选择的一只眼睛中滴入一滴0.5%托吡卡胺或1%阿托品。在滴药前以及滴药后0.25小时、0.5小时、0.75小时、1小时、2小时、4小时、6小时、8小时、10小时、12小时、24小时、36小时、48小时、60小时和72小时评估PD、IOP和TP。使用配对双样本重复测量T检验并进行Bonferroni校正分析数据。

结果

在托吡卡胺和阿托品治疗的眼睛中,治疗后15分钟至12小时平均PD显著增加,在45分钟时达到最大PD(分别增加2.7毫米和2.4毫米)。与未治疗的眼睛相比,滴入托吡卡胺和阿托品后,治疗的眼睛在45分钟(增加2.9毫米汞柱)和15分钟(增加5.2毫米汞柱)时IOP显著升高。在任何时候,托吡卡胺和阿托品治疗的眼睛对TP均未发现显著影响。两种药物在未治疗的眼睛中对所评估的任何参数均未观察到影响。

结论

局部应用0.5%托吡卡胺和1%阿托品可使健康宠物兔散瞳,在需要散瞳/睫状肌麻痹药物时可被视为有效选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验